European Cancer Forum 2025: Innovation, Security and Sustainability
DUO-O trial: Durvalumab + Bevacizumab + Olaparib Improves PFS in Newly Diagnosed BRCA-Wild-Type Ovarian Cancer
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening
A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma
CancerWorld Issue #110 (December) is Live
Samra Turajlić: Honoured to Receive the 2026 Pezcoller–EACR Translational Cancer Award
Tanja Obradovic: Eventful 2025 Year for Cancer Drugs-45 New or Accelerated Approvals by FDA
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
1 event,
The ESMO Breast Cancer Congress 2025 will take place in Munich, Germany, on May 14-17, 2025, with an online option available through a dedicated virtual platform. It is organized by the European Society For Medical Oncology. This focused event will bring together international experts to explore the latest innovations, discuss cutting-edge treatments, and collaborate on […] |
1 event,
|
1 event,
|
1 event,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
ASCO Annual Meeting 2025 will be held from May 30 - June 3, 2025 at Chicago, Illinois. The 2025 ASCO Annual Meeting will focus on driving cancer research into actionable change, in line with Dr. Robin Zon's theme Driving Knowledge to Action: Building a Better Future. The program will feature key sessions such as the […] |
1 event,
|
1 event,
|